NEW YORK, NY / ACCESSWIRE / November 29, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Covetrus, Inc. (NASDAQ:CVET)

Investors Affected : February 8, 2019 – August 12, 2019

A class action has commenced on behalf of certain shareholders in Covetrus, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company had overstated its capabilities with regard to inventory management and supply chain services; (ii) Covetrus had understated the costs of the integration of Henry Schein’s Animal Health Business and VFC, including the timing and nature of those costs; (iii) Covetrus had understated its separation costs from Henry Schein; and (iv) the Company understated the impact on earnings from online competition and alternative distribution channels as well as the impact of the loss of a large customer in North America just prior to the Company’s separation from Henry Schein.

Shareholders may find more information at https://securitiesclasslaw.com/securities/covetrus-inc-loss-submission-form/?id=4658&from=1

Canopy Growth Corporation (NYSE:CGC)

Investors Affected : June 21, 2019 – November 13, 2019

A class action has commenced on behalf of certain shareholders in Canopy Growth Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing weak demand for its softgel and oil products; (2) as a result, the Company would be forced to take a CA$32.7 million restructuring charge due to poor sales, excessive returns, and excess inventory; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/canopy-growth-corporation-loss-submission-form/?id=4658&from=1

Aurora Cannabis Inc. (NYSE:ACB)

Investors Affected : September 11, 2019 – November 14, 2019

A class action has commenced on behalf of certain shareholders in Aurora Cannabis Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) as opposed to the Company’s representations, Aurora’s revenue would decline in its first quarter of fiscal 2020 ended September 30, 2019; (2) the Company would halt construction on its Aurora Nordic 2 and Aurora Sun facilities; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/aurora-cannabis-inc-loss-submission-form/?id=4658&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 568549

LOS ANGELES, CA / ACCESSWIRE / November 29, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sealed Air Corporation ("Sealed Air" or "the Company") (NYSE:SEE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission."

Investors who purchased the Company's securities between November 5, 2014 and August 6, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before December 31, 2019.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Sealed Air improperly deducted $1.49 billion related to the settlement of asbestos liabilities from its taxes to artificially inflate its financial performance. The Company switched auditors to help facilitate this fraud. On August 6, 2018, the Company admitted that it had received a subpoena from the SEC related to the Company's accounting for taxes and financial disclosures. Based on these facts, the company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Sealed Air, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 568552

LOS ANGELES, CA / ACCESSWIRE / November 29, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against UP Fintech Holding Limited ("UP Fintech" or "the Company") (NASDAQ:TIGR) for violations of the federal securities laws.

Investors who purchased UP Fintech securities pursuant and/or traceable to the Company's initial public offering conducted on or about March 20, 2019 (the "IPO"); or between March 20, 2019 and May 16, 2019, both dates inclusive (the "Class Period"), are encouraged to contact the firm before January 6, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. UP Fintech suffered a drop in commissions due to an ongoing downtrend amongst risk-averse investors. The Company failed to manage the costs of its quick growth and raised profile of being listed on a U.S. exchange. The Company also had increased costs associated with headcount and benefits. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about UP Fintech, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 568548

VANCOUVER, BC / ACCESSWIRE / November 29, 2019 / Eastwest Bioscience Inc. ("Eastwest" or the "Corporation") provides this default announcement indicating Eastwest's anticipated failure to file its annual financial statements for the year ended July 31, 2019 and related management discussion and analysis and certifications (collectively, the "Financial Statements") before the prescribed filing deadlines.

The Corporation's failure to file its Financial Statements on time is due to the following circumstances:

The Corporation acquired Sangster's Health Centres ("Sangster's") with three subsidiaries on November 30, 2018. Two of the Corporation's existing subsidiaries have a significant volume of sales to Sangster's and there are a significant volume of sales between the Sangster's subsidiaries which need to be eliminated upon consolidation. The consolidation of the three subsidiaries has been an onerous process and has added complexity to the Corporation's audit.

The Corporation has been in dispute with the seller of Sangster's with respect to the underperformance of Sangster's and issues surrounding the purchase and sale agreement. The ongoing negotiation, financial review of the Corporation by the seller, and preparation for litigation has consumed the time and resources of the CFO of the Corporation and has added complexity to the Corporation's audit. Also, there is a pending settlement agreement with the seller which may have a material impact on the financial statements of the Corporation and may require additional work for the completion of the audit.

Due to the underperformance of Sangster's, restructuring was required to cut costs and streamline operations and reporting. Changes in staffing, changes to reporting systems, and additional work required to plan and implement the restructuring process has consumed the resources of the Corporation and delayed the work required for completion of the Corporation's audit.

The Controller and the Office Administrator responsible for accounting clerk duties of the Sangster's group of companies both resigned for personal reasons in June 2019. The departure of these two staff members and training of replacement staff significantly delayed the accounting work for Sangster's year end, the consolidation of the Sangster's financial records, and the completion of the Corporation's audit.

Considering the foregoing factors, it is Eastwest's submission that the present circumstances warrant the imposition of a Management Cease Trade Order ("MCTO"), rather than a Cease Trade Order ("CTO"), as contemplated under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203").

Eastwest's Financial Statements are required to be filed on or before January 29, 2020. Eastwest's failure to file by January 29, 2020 may result in the securities commissions or regulators imposing an Issuer CTO.

Eastwest fully expects to file its Financial Statements on or before January 29, 2020 as prescribed by NP 12-203. Further, Eastwest confirms that it intends to satisfy the requirements to provide Default Status Reports as prescribed by NP 12-203 so long as it remains in default of its requirements to file its Financial Statements within the prescribed period of time. Should Eastwest fail to file the appropriate Default Status Reports as prescribed by NP 12-203, the securities commissions or regulators may, as a result of such failure, impose an Issuer CTO.

Eastwest confirms that there are no insolvency proceedings against the Corporation as of the date herein. Eastwest also confirms that there is no other material information concerning the affairs of Eastwest that have not been generally disclosed as of the date herein.

ON BEHALF OF THE BOARD OF DIRECTORS

EASTWEST BIOSCIENCE GROUP

"Rodney Gelineau"
Chief Executive Officer and Director

"Paul Marjerrison"
Chief Financial Officer

TSXV – Symbol: EAST

Company Website: www.eastwestbioscience.com
Contact: Rodney Gelineau on 1-800-409-1930 or investors@eastwestscience.com.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the terms and conditions of the Corporation's filing of annual financial statements for the fiscal year ended July 31, 2019 and the related management's discussion and analysis and the MCTO. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: management's perceptions of the anticipated timeline in which the Filings can be completed and filed, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: EastWest Bioscience Inc.

ReleaseID: 568568

VANCOUVER, BC / ACCESSWIRE / November 29, 2019 / Belmont Resources Inc (TSXV:BEA) ("Belmont"), (or the "Company"). Further to our news release of October 22, 2019 the Company will be applying to the Exchange for a 30 day extension to close the financings.

Financings – Flow-Through and NFT

The Company intends to complete a non-brokered private placement of 3 million units at a price of six cents ($0.06) per unit to raise gross proceeds of up to $180,000. Each unit will consist of one common share of the Company and one transferable share purchase warrant. Each warrant will permit the holder to acquire one additional share of the Company at 8 cents for 18 months after closing. The term of the warrants may be accelerated in the event that the issuer's shares trade at or above a price of 20 cents per share for a period of 10 consecutive days. In such case of accelerated warrants, the Company may give notice, in writing or by way of news release, to the subscribers that the warrants will expire 30 days from the date of providing such notice.

In addition the Company intends to complete a non-brokered private placement of 2 million units at a price of six and one-half cents ($0.065) per unit to raise gross proceeds of up to $120,000. Each unit will consist of one common share (which is a flow-through -FT share for Canadian income tax purposes) of the Company and one non flow-through (NFT) transferable share purchase warrant. Each warrant will permit the holder to acquire one additional share of the Company at 8 cents for 18 months after closing. The term of the warrants may be accelerated in the event that the issuer's shares trade at or above a price of 20 cents per share for a period of 10 consecutive days. In such case of accelerated warrants, the Company may give notice, in writing or by way of news release, to the subscribers that the warrants will expire 30 days from the date of providing such notice.

In addition to relying upon other available prospectus exemptions to effect the Financing, a portion of the private placement may be completed in accordance with the exemption set out in BC Instrument 45-536 (Exemption from prospectus requirement for certain distributions through an investment dealer), (the "Investment Dealer Exemption"). The Company also confirms there is no material fact or material change related to the Company which has not been generally disclosed.

The Company may pay commissions of 8% to eligible parties in connection with this financing, payable either in cash and/or in warrants. The Common Shares and Warrants are subject to a statutory hold period of four months and one day after closing. Completion of the financing is subject to TSX Venture Exchange ("TSXV") approval.

The Company intends to use the proceeds from the financing for working capital and exploration on properties.

Directors, officers or other insiders of the Company may participate in the foregoing offerings, and such parties may sell securities of the Company owned or controlled by them personally through the facilities of the TSX Venture Exchange to finance participation in such offerings.

About Belmont Resources Inc.

Belmont Resources Inc. is a Canadian based resource company traded on the TSX-V under the symbol "BEA". The Company is systematically exploring its extensive property positions in British Columbia (Gold), Nevada (Lithium) and Saskatchewan (Uranium).

ON BEHALF OF THE BOARD OF DIRECTORS

"George Sookochoff"

George Sookochoff, CEO/President
Director
Ph: 604-683-6648
Email: george@belmontresources.com
Website: www.BelmontResources.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as the term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

This Press Release may contain forward-looking statements that may involve a number of risks and uncertainties, based on assumptions and judgments of management regarding future events or results that may prove to be inaccurate as a result of exploration and other risk factors beyond its control. Forward looking statements in this news release include statements about the possible raising of capital and exploration of our properties. Actual events or results could differ materially from the Companies forward-looking statements and expectations. These risks and uncertainties include, among other things, that we may not be able to obtain regulatory approval; that we may not be able to raise funds required, that conditions to closing may not be fulfilled and we may not be able to organize and carry out an exploration program in 2019, and other risks associated with being a mineral exploration and development company. These forward-looking statements are made as of the date of this news release and, except as required by applicable laws, the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.

SOURCE: Belmont Resources Inc.

ReleaseID: 568558

VANCOUVER, BC / ACCESSWIRE / November 29, 2019 / Majestic Gold Corp. ("Majestic" or the "Company") (TSXV:MJS)(FSE:A0BK1D) reports its financial and operational results for the fourth quarter ended September 30, 2019. This release should be read in conjunction with the Company's unaudited condensed consolidated interim financial statements and associated management discussion and analysis ("MD&A") for the same period that are available on SEDAR (www.sedar.com) and www.majesticgold.com. The following financial results are expressed in US dollars unless otherwise stated.

FOURTH QUARTER 2019 HIGHLIGHTS

Gold production was 6,273 ounces for the fourth quarter of 2019, compared to 6,123 ounces produced for the 2018 comparative quarter;

Gold sales revenue reached $7.1 million for the fourth quarter of fiscal 2019, from the sale of 5,524 ounces, at an average realized gold price of $1,280 per ounce, compared to gold sales revenue of $6.1 million from the sale of 5,102 ounces, at an average realized gold price of $1,203 per ounce, for the 2018 comparative quarter. The 15% increase in gold sales revenue for the current quarter is primarily due to an 8% increase in ounces sold and 6% increase in average realized price;

Total cash costs and all-in sustaining costs ("AISC") for the fourth quarter of fiscal 2019 were $593 per ounce and $838 per ounce, compared to $658 per ounce and $826 per ounce for the 2018 comparative quarter. The cash costs and all-in sustaining costs for the first twelve months of fiscal 2019 were $613 per ounce and $752 per ounce, compared to $651 per ounce and $774 per ounce for the 2018 comparative period. The Company continues to work in maintaining its cash costs and AISC averages below $675 per ounce and $775 per ounce, respectively. Refer to pages 13-15 for the MD&A for the computation of this Non-IFRS financial measure;

Adjusted EBITDA was $3,036,643 for the fourth quarter of 2019, compared to $2,030,064 for the comparative quarter of fiscal 2018. Adjusted EBITDA for the first twelve months of 2019 was $14,063,228, compared to $14,244,144 for the comparative period of fiscal 2018. Refer to pages 13-15 of the MD&A for the computation of this Non-IFRS financial measure;

Net income for the fourth quarter of 2019 was $2,222,525, compared to $569,384 for the 2018 comparative quarter;

The Company's balance sheet benefitted from the fourth quarter of 2019's operating and financial performance, increasing its cash to $21.8 million at September 30, 2019 from $18.8 million at September 30, 2018. As of September 30, 2019, the Company had working capital of $6.4 million compared to a working capital deficit of $2.2 million at September 30, 2018; and

On October 23, 2019, the Company announced it had entered into three separate non-binding Memorandums of Understanding ("MOUs") with three different groups on four gold projects located in the Muping-Rushan gold belt in eastern Shandong Province, China.

FINANCIAL INFORMATION

 
Three months ended
September 30,
 
 
Twelve months ended
September 30,
 

 
2019
 
 
2018
 
 
2019
 
 
2018
 

Operating data

Gold produced (ozs)

 
 
6,273
 
 
 
6,123
 
 
 
28,395
 
 
 
29,160
 

Gold realized net of smelting fees (ozs)

 
 
5,870
 
 
 
5,729
 
 
 
26,138
 
 
 
26,645
 

Gold sold (ozs)

 
 
5,524
 
 
 
5,102
 
 
 
25,244
 
 
 
25,584
 

Average realized gold price ($/oz sold)

 
$
1,280
 
 
$
1,203
 
 
$
1,274
 
 
$
1,308
 

Total cash costs ($/oz sold) (1)

 
 
593
 
 
 
658
 
 
 
613
 
 
 
651
 

Total production costs ($/oz sold) (1)

 
 
785
 
 
 
834
 
 
 
784
 
 
 
811
 

All-in sustaining costs ($/oz sold) (1)

 
 
838
 
 
 
826
 
 
 
752
 
 
 
774
 

Financial data

Total revenues

 
$
7,119,195
 
 
$
6,214,381
 
 
$
32,431,989
 
 
$
33,804,198
 

Gross profit (2)

 
 
2,779,777
 
 
 
1,957,951
 
 
 
12,632,357
 
 
 
13,046,333
 

Adjusted EBITDA (1)

 
 
3,036,643
 
 
 
2,030,064
 
 
 
14,063,228
 
 
 
14,244,144
 

Net income

 
 
2,222,525
 
 
 
569,384
 
 
 
7,393,414
 
 
 
6,876,418
 

Net income attributable to shareholders

 
 
1,680,720
 
 
 
297,724
 
 
 
5,048,031
 
 
 
4,397,090
 

Basic and diluted gain per share

 
 
0.00
 
 
 
0.00
 
 
 
0.01
 
 
 
0.01
 

 
 
 
 
 
 
 
 
 
September 30,
 
 
September 30,
 

 
 
 
 
 
 
 
 
 
 
2019
 
 
 
2018
 

Cash

 
 
 
 
 
 
 
 
 
$
21,814,635
 
 
$
18,842,863
 

Total assets

 
 
 
 
 
 
 
 
 
 
120,077,016
 
 
 
123,643,469
 

Total current liabilities

 
 
 
 
 
 
 
 
 
 
23,683,232
 
 
 
29,182,046
 

(1) See "Additional Non-IFRS Financial Measures" on pages 13-15 in the Company's MD&A.
(2) "Gross profit" represents total revenues, net of cost of goods sold.

About Majestic Gold

Currently focused solely in China, Majestic Gold Corp. is a British Columbia based company engaged in commercial gold production at the Songjiagou Gold Mine in eastern Shandong Province, China. Additional information on the Company and its projects is available at www.sedar.com and on the Company's website at www.majesticgold.com.

For further information, please contact:

Stephen Kenwood, P.Geo., President and CEO
Telephone: (604) 560-9060
Email: info@majesticgold.com
Website: www.majesticgold.com

Cautionary Notes

Certain statements contained herein may constitute forward‐looking statements and are made pursuant to the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Forward‐looking statements are statements which relate to future events. Such statements include estimates, forecasts and statements as to management's expectations with respect to, among other things, business and financial prospects, financial multiples and accretion estimates, future trends, plans, strategies, objectives and expectations, including with respect to production, exploration drilling, reserves and resources, exploitation activities and events or future operations. Information inferred from the interpretation of drilling results and information concerning mineral resource estimates may also be deemed to be forward-looking statements, as it constitutes a prediction of what might be found to be present when, and if, a project is actually developed.

In some cases, you can identify forward‐looking statements by terminology such as "may", "should", "expects", "plans, "anticipates", believes", "estimates", "predicts", "potential", or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, level of activity, performance or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward‐looking statements.

While these forward‐looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggestions herein. Except as required by applicable law, Majestic Gold does not intend to update any forward‐looking statements to conform these statements to actual results.

SOURCE: Majestic Gold Corp.

ReleaseID: 568554

LOS ANGELES, CA / ACCESSWIRE / November 29, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Match Group, Inc. ("Match" or "the Company") (NASDAQ:MTCH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission."

Investors who purchased the Company's securities between August 6, 2019 and September 25, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before December 2, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Match used fake messages of interest to lure customers into buying subscriptions and upgrades. At the same time, the Company made it difficult and confusing for customers to cancel subscriptions. The Company also lacked appropriate controls on disclosure. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Match, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 568543

LOS ANGELES, CA / ACCESSWIRE / November 29, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Altria Group, Inc. ("Altria" or "the Company") (NYSE:MO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between December 20, 2018 and September 24, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before December 2, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Altria failed to conduct strong due diligence before taking a 35% stake JUUL. The Company did not inform investors about the marketing practices or true value of JUUL. Public scrutiny, negative publicity, and government pressure on JUUL, among other factors, were likely to negatively impact the Company's reputation and operations. Based on these facts, the Company's public statements were false and materially misleading. When the market learned the truth about Altria, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 568541

LOS ANGELES, CA / ACCESSWIRE / November 29, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fiat Chrysler Automobiles N.V. ("Fiat Chrysler" or "the Company") (NYSE:FCAU) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. General Motors Company ("GM") filed a federal racketeering lawsuit against Fiat Chrysler and its former executives on November 20, 2019, alleging that the Company bribed UAW officials to gain favorable terms in labor negotiations. GM Alleges that the Company "corrupted" negotiations and collective bargaining agreements between GM and the UAW in 2009, 2011, and 2015. GM alleges that to accomplish this goal, Fiat Chrysler paid millions in bribes authorized by the highest levels of Fiat Chrysler management. Based on this news, shares of Fiat Chrysler fell by 3.72% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 568539

LOS ANGELES, CA / ACCESSWIRE / November 29. 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Covetrus, Inc. ("Covetrus" or "the Company") (NASDAQ:CVET) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission." type="text"> The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Covetrus, Inc. ("Covetrus" or "the Company") (NASDAQ:CVET) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities are encouraged to contact the firm before November 29, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Covetrus overstated its skills and abilities in inventory management and supply chain services. The Company understated the costs associated with the integration of Henry Schein's Animal Health Business and VFC. The Company also downplayed the impact of online competition and alternate distribution channels on earnings performance. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Covetrus, investors suffered damages.

The Schall Law Firm represents investors around the world and focuses on securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 568534